コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ndistinguishable from that for the histamine H3 receptor.
2 and subnanomolar affinities at human and rat H3 receptors.
3 hanism that does not utilize brain H1, H2 or H3 receptors.
4 H1 or H2 receptors, but had weak activity on H3 receptors.
5 ptors, adenosine A1-receptors, and histamine H3-receptors.
9 bination therapy of sigma1R antagonists with H3 receptor agonists could serve to reduce some effects
11 or antagonist cimetidine (20 microM) nor the H3 receptor antagonist thioperamide (20 microM) prevente
13 safety of pitolisant, a selective histamine H3 receptor antagonist with wake-promoting effects, for
17 d the relative efficacy of a novel selective H3-receptor antagonist, JNJ-39220675, in preventing nasa
20 This series represents a new scaffold of H3 receptor antagonists that demonstrates in vivo exposu
24 in several disease models, its binding to a H3 receptor as well as a hERG channel prevented it from
26 0.13 nM) demonstrated a stereopreference in H3 receptor binding affinity for the (1R,2R) enantiomer
27 ioligand for determination of human cerebral H3 receptor binding and allows highly reproducible in vi
28 ptor antagonist, but not by selective H1 and H3 receptor blockers, and were mimicked by an H2 recepto
31 directly via H2 receptors and indirectly via H3 receptors coupled to inhibition of somatostatin secre
32 eviously showed that prejunctional histamine H3-receptors downregulate norepinephrine exocytosis, whi
33 mplies that endogenous histamine, acting via H3 receptors, exerts an inhibitory paracrine influence o
37 Ciproxifan is a well-investigated histamine H3 receptor (H3R) inverse agonist/antagonist, showing an
38 rs of the biologic effects of histamine, the H3 receptor (H3R) is distinguished for its almost exclus
40 oamine oxidases A/B as well as the histamine H3 receptor (H3R) were obtained by optimization of the n
42 wild-type animals, mice with a disrupted HA H3 receptor (H3RKO), the expression of which is normally
44 , S) have been synthesized and evaluated for H3-receptor histamine antagonism in vitro (Ki for [3H]hi
45 cription-PCR analysis revealed expression of H3 receptors in a population of GABAergic neurons, while
46 ine (6), was discovered to bind to histamine H3 receptors in a radioligand-based high-throughput scre
47 was designed to characterize the location of H3 receptors in the fundus of the stomach and the mechan
49 134, 2 potential IA drugs targeting cerebral H3 receptors, in 6 healthy male subjects (age, 19-40 y).
51 a(2+) channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent s
54 tor by an antagonist restores the protective H3 receptor-mediated brake on D1 receptor signaling and
55 ition binding as well as functional tests of H3 receptor-mediated calcium mobilization and GTPgammaS
56 m may be cocaine's blockade of the histamine H3 receptor-mediated inhibition of D1 receptor function.
58 n the present study, we investigated whether H3-receptors modulate nonexocytotic norepinephrine relea
59 r biodistribution, quantification, and brain H3 receptor occupancy (RO) of MK-0249 and MK-3134, 2 pot
61 rain-penetrant antagonist/inverse agonist of H3 receptors, on AHN (proliferation, maturation and surv
62 isplayed high affinity at both rat and human H3 receptors (pKi = 7.61 and 8.27) and generally high se
63 acid secretion induced by the activation of H3 receptors reflected changes in somatostatin secretion
65 antinociception is mediated by an action on H3 receptors, the effects of the H3 agonist R-alpha-meth
66 or was found to closely resemble that of the H3 receptor; the major difference was that (R)-alpha-met